Clinical Trial Update: The REALITY Study - a Real-life Long-term Analysis of Xolair Therapy

View source ↗

Summary

This document provides an update on the REALITY study, a real-world, long-term analysis of omalizumab (Xolair) therapy for allergic asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Asthma

Drugs mentioned

• Xolair (omalizumab)

Snippet

Sponsor: Joseph D. Diaz, MD | Conditions: Allergic Asthma | Status: UNKNOWN